Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Klaus Bosslet"'
Autor:
Frieder Bauss, Martin Lechmann, Ben-Fillippo Krippendorff, Roland Staack, Frank Herting, Matthias Festag, Sabine Imhof-Jung, Friederike Hesse, Marc Pompiati, Gwendlyn Kollmorgen, Rita da Silva Mateus Seidl, Birgit Bossenmaier, Wilma Lau, Christian Schantz, Jan O. Stracke, Ulrich Brinkmann, Masanori Onda, Ira Pastan, Klaus Bosslet, Gerhard Niederfellner
Publikováno v:
Molecular Oncology, Vol 10, Iss 8, Pp 1317-1329 (2016)
Mesothelin overexpression in lung adenocarcinomas correlates with the presence of activating KRAS mutations and poor prognosis. Hence SS1P, a mesothelin‐targeted immunotoxin, could offer valuable treatment options for these patients, but its use in
Externí odkaz:
https://doaj.org/article/016854fb9481433287e7d8721af2694e
Autor:
H.-Harald Sedlacek, Dieter Hoffmann, Jörg Czech, Cenek Kolar, Gerhard Seemann, Dettef Güssow, Klaus Bosslet
Publikováno v:
CHIMIA, Vol 45, Iss 10 (1991)
Externí odkaz:
https://doaj.org/article/41a7b8d1646f4160aa8f63558495437e
Autor:
Ira Pastan, Klaus Bosslet, Gerhard Niederfellner, Takao Yamori, Laiman Xiang, Christine Alewine
Supplementary Figure 2. Demonstrates no activity of a control non-binding immunotoxin in vitro and in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f436a7217bf03d95373a8c7bd2846b
https://doi.org/10.1158/1535-7163.22502506
https://doi.org/10.1158/1535-7163.22502506
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
Supplementary information on cell maintenance, and antibody selection and characterization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e363db33bfb70119118f019496cf74f
https://doi.org/10.1158/1535-7163.22507438.v1
https://doi.org/10.1158/1535-7163.22507438.v1
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
FAP-drozitumab antibody-mediated apoptosis does not correlate with DR5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3902da6fa0a7fedce1633f385c71997d
https://doi.org/10.1158/1535-7163.22507435.v1
https://doi.org/10.1158/1535-7163.22507435.v1
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
Characterization and optimization of RG7386 dosing in vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce9ad07c4aa7036fe31ed07f7a16bea
https://doi.org/10.1158/1535-7163.22507444.v1
https://doi.org/10.1158/1535-7163.22507444.v1
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
Dysregulated cellular apoptosis and resistance to cell death are hallmarks of neoplastic initiation and disease progression. Therefore, the development of agents that overcome apoptosis dysregulation in tumor cells is an attractive therapeutic approa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::494461f0b5e8179b32511522a796418b
https://doi.org/10.1158/1535-7163.c.6538687.v1
https://doi.org/10.1158/1535-7163.c.6538687.v1
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
Figure S2. Related to Figure 3. In vitro characterization of the FAP-DR5 BsAb RG7386; Table S4. Characterization of RG7386 binding avidities.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3801c0935929b8b4a51298f3d1fcd860
https://doi.org/10.1158/1535-7163.22507447.v1
https://doi.org/10.1158/1535-7163.22507447.v1
Autor:
Ira Pastan, Klaus Bosslet, Gerhard Niederfellner, Takao Yamori, Laiman Xiang, Christine Alewine
Supplementary Figure 1. Shows evaluation of MSLN expression in the TCGA breast cancer data set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd36cf91ad34910aded61e08c7d3a8e
https://doi.org/10.1158/1535-7163.22502509.v1
https://doi.org/10.1158/1535-7163.22502509.v1
Autor:
Ira Pastan, Klaus Bosslet, Gerhard Niederfellner, Takao Yamori, Laiman Xiang, Christine Alewine
Supplementary Figure 4. Shows cell killing with combination paclitaxel and RG7787 in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08dbba89ed29322bd37affe7bb24c754
https://doi.org/10.1158/1535-7163.22502497.v1
https://doi.org/10.1158/1535-7163.22502497.v1